Citation Impact

Citing Papers

Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
2018 StandoutScienceNobel
A large fraction of HLA class I ligands are proteasome-generated spliced peptides
2016 Science
Adenosine 2B Receptor Expression on Cancer Cells Promotes Metastasis
2016
Efficient Identification of Mutated Cancer Antigens Recognized by T Cells Associated with Durable Tumor Regressions
2014
Topological control of cytokine receptor signaling induces differential effects in hematopoiesis
2019 StandoutScienceNobel
Anti–CTLA-4 therapy broadens the melanoma-reactive CD8 + T cell response
2014
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
In vivo mRNA delivery to virus-specific T cells by light-induced ligand exchange of MHC class I antigen-presenting nanoparticles
2022
Degradation of proteins by PROTACs and other strategies
2019
5-Azacytidine treatment sensitizes tumor cells to T-cell mediated cytotoxicity and modulates NK cells in patients with myeloid malignancies
2014
Ubiquitin ligation to F-box protein targets by SCF–RBR E3–E3 super-assembly
2021 Nature
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
Engineering precision nanoparticles for drug delivery
2020 Standout
Determining cell type abundance and expression from bulk tissues with digital cytometry
2019 Standout
Case Report of a Fatal Serious Adverse Event Upon Administration of T Cells Transduced With a MART-1-specific T-cell Receptor
2015
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Clonal Deletion Prunes but Does Not Eliminate Self-Specific αβ CD8+ T Lymphocytes
2015
Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells
2022 StandoutNobel
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Human cancer regression antigens
2013
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Shielding the cationic charge of nanoparticle-formulated dermal DNA vaccines is essential for antigen expression and immunogenicity
2009
In-solution enrichment identifies peptide inhibitors of protein–protein interactions
2019
Beyond model antigens: high-dimensional methods for the analysis of antigen-specific T cells
2014
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
Post-Translational Peptide Splicing and T Cell Responses
2017
The cancer antigenome
2012
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
2014 StandoutNature
Viral acute lower respiratory infections impair CD8+ T cells through PD-1
2012
Delivery technologies for cancer immunotherapy
2019 Standout
Light‐Controlled Tools
2012
Sources of diversity in T cell epitope discovery
2011
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
2015 Standout
Anchor extension: a structure-guided approach to design cyclic peptides targeting enzyme active sites
2021 StandoutNobel
mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model
2022 StandoutNobel
cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity
2020 Nature
Regulatory T cells in cancer immunotherapy
2016 StandoutNobel
Regulation and Function of the PD-L1 Checkpoint
2018 Standout
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
A bromocoumarin-based linker for synthesis of photocleavable peptidoconjugates with high photosensitivity
2008
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
PROTAC targeted protein degraders: the past is prologue
2022 Standout
Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
2017 Standout
Kinase inhibitors: the road ahead
2018
Fluorescent and colorimetric sensors for detection of lead, cadmium, and mercury ions
2011 Standout
Immunity, inflammation and cancer: a leading role for adenosine
2013
Orthogonal photoswitching in a multifunctional molecular system
2016 StandoutNobel
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
2019 StandoutNobel
Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma
2018
The human skin microbiome
2018 Standout
An in vivo screening system to identify tumorigenic genes
2016
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Photoremovable Protecting Groups in Chemistry and Biology: Reaction Mechanisms and Efficacy
2012 Standout
Regulatory T Cells and Human Disease
2020 StandoutNobel
Targeting Treg cells in cancer immunotherapy
2019 StandoutNobel
Lighting the way to personalized mRNA immune cell therapies
2022
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
2020 Standout
Wavelength-selective cleavage of photoprotecting groups: strategies and applications in dynamic systems
2015 StandoutNobel
Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive Melanoma
2013
Catalytic and Molecular Beacons for Amplified Detection of Metal Ions and Organic Molecules with High Sensitivity
2010
Synthesis and anticancer activity studies of novel 1-(2,3-dihydro-5H-1,4-benzodioxepin-3-yl)uracil and (6′-substituted)-7- or 9-(2,3-dihydro-5H-1,4-benzodioxepin-3-yl)-7H- or 9H-purines
2006
Unifying Catalysis Framework to Dissect Proteasomal Degradation Paradigms
2021
Direct and Versatile Synthesis of Red‐Shifted Azobenzenes
2016 StandoutNobel
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
2018 StandoutNobel
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Blockade of A 2A receptors potently suppresses the metastasis of CD73 + tumors
2013
Artificial Molecular Machines
2015 Standout
Development and photo-responsive peptide bond cleavage reaction of two-photon near-infrared excitation-responsive peptide
2010
The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets
2017
A New Class of Rigid Multi(azobenzene) Switches Featuring Electronic Decoupling: Unravelling the Isomerization in Individual Photochromes
2019 StandoutNobel
Detection of T cell responses to a ubiquitous cellular protein in autoimmune disease
2014 StandoutScienceNobel
An Adenosine-Mediated Signaling Pathway Suppresses Prenylation of the GTPase Rap1B and Promotes Cell Scattering
2013
Lichtgesteuerte Werkzeuge
2012
On Terminal Alkynes That Can React with Active-Site Cysteine Nucleophiles in Proteases
2013
o-Fluoroazobenzenes as Readily Synthesized Photoswitches Offering Nearly Quantitative Two-Way Isomerization with Visible Light
2012 Standout
Aromatic Trifluoromethylation with Metal Complexes
2011 Standout
Emerging Targets in Photopharmacology
2016 StandoutNobel
Neoantigens in cancer immunotherapy
2015 StandoutScience
Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti–COVID-19 drug design
2020
Targeting Cancer-Derived Adenosine:New Therapeutic Approaches
2014
Immune Checkpoint Blockade in Cancer Therapy
2015 Standout
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Unraveling the Photoswitching Mechanism in Donor–Acceptor Stenhouse Adducts
2016 StandoutNobel
Mucosal Immunization with a pH-Responsive Nanoparticle Vaccine Induces Protective CD8+ Lung-Resident Memory T Cells
2019
“Inverse Drug Discovery” Strategy To Identify Proteins That Are Targeted by Latent Electrophiles As Exemplified by Aryl Fluorosulfates
2017 StandoutNobel

Works of Boris Rodenko being referenced

Design and use of conditional MHC class I ligands
2006
Generation of peptide–MHC class I complexes through UV-mediated ligand exchange
2006
Transpeptidation and reverse proteolysis and their consequences for immunity
2008
High-Throughput T-Cell Epitope Discovery Through MHC Peptide Exchange
2009
Proteasome Activation by Small Molecules
2017
Ubiquitin‐Based Probes Prepared by Total Synthesis To Profile the Activity of Deubiquitinating Enzymes
2012
UV-Induced Ligand Exchange in MHC Class I Protein Crystals
2009
Peptide Splicing in the Proteasome Creates a Novel Type of Antigen with an Isopeptide Linkage
2015
Class I Major Histocompatibility Complexes Loaded by a Periodate Trigger
2009
Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis
2013
Solid phase synthesis of C2,N6-disubstituted adenosine analogues
2002
Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7
2008
Definition of Proteasomal Peptide Splicing Rules for High-Efficiency Spliced Peptide Presentation by MHC Class I Molecules
2015
Generation of Peptide MHC Class I Monomers and Multimers Through Ligand Exchange
2009
Rankless by CCL
2026